These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm. Zaitoun MMA, Elsayed SB, Zaitoun NA, Soliman RK, Elmokadem AH, Farag AA, Amer M, Hendi AM, Mahmoud NEM, Salah El Deen D, Alsowey AM, Shahin S, Basha MAA. Int J Hyperthermia; 2021 Nov; 38(1):248-256. PubMed ID: 33615957 [Abstract] [Full Text] [Related]
5. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis. Shuanggang C, Shen L, Qiu Z, Qi H, Cao F, Xie L, Fan W. J Cancer Res Ther; 2020 Nov; 16(2):250-257. PubMed ID: 32474509 [Abstract] [Full Text] [Related]
6. Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study. Shi Q, Wang F, Du N, Zhou Y, Zhou X, Ma J, Yang M, Zhang Z, Yu J, Zhang W, Luo J, Liu L, Yan Z. Clin Res Hepatol Gastroenterol; 2022 Nov; 46(7):101986. PubMed ID: 35772684 [Abstract] [Full Text] [Related]
7. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ. Biomed Res Int; 2021 Nov; 2021():6670367. PubMed ID: 34337041 [Abstract] [Full Text] [Related]
11. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness. Huang T, Qi H, Shen L, Wu Y, Song Z, Cao F, Liu Y, Xie L, Chen S, Tang T, Li H, Zhang Y, Feng L, Zhang H, Chen J, Fan W. Int J Hyperthermia; 2022 Nov; 39(1):935-945. PubMed ID: 35853727 [Abstract] [Full Text] [Related]
12. Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis. Shi Q, Liu J, Li T, Zhou C, Wang Y, Huang S, Yang C, Chen Y, Xiong B. Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101893. PubMed ID: 35247625 [Abstract] [Full Text] [Related]
13. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A). Lee H, Yoon CJ, Seong NJ, Jeong SH, Kim JW. Korean J Radiol; 2018 May; 19(6):1130-1139. PubMed ID: 30386144 [Abstract] [Full Text] [Related]
17. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone. Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT, Laeseke P. Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606 [Abstract] [Full Text] [Related]